Total recall of Tredaptive (Extended Release Niacin/Laropiprant) 1g/20mg Tablet (with photo)

The Department of Health today (January 21) endorsed the total recall of Tredaptive (ER Niacin/Laropiprant) 1g/20mg Tablet (Registration number: HK-57317) (Tredaptive) from the market by licensed drug wholesaler Merck Sharp & Dohme (Asia) Ltd because new data showed that the benefits of the product no longer outweigh the risks for patients.